Sanofi-Aventis announces availability of insulin pen in the United States
BRIDGEWATER, N.J. A disposable insulin pen for patients ages 4 and older with Type 1 diabetes and adults with Type 2 diabetes has become available in the United States.
Sanofi-Aventis U.S. announced Monday the availability of the Apidra SoloSTAR, a pen with the fast-acting insulin analog Apidra (insulin glulisine [rDNA origin]). The pen received Food and Drug Administration approval in February, following the approval and launch of the long-acting Lantus SoloSTAR (insulin glargine [rDNA origin]).
“Sanofi-Aventis is committed to providing innovative tools to patients with diabetes that can help ease some of the challenges of blood sugar management,” stated Jerry Durso, Sanofi-Aventis U.S. VP Specialized Therapeutics Business Unit. “Apidra SoloSTAR provides patients with a convenient option for administering their Apidra.”
Study finds racial bias in measuring of BMI, obesity rates
NEW YORK The rise in obesity in the United States over the last 20 years has been dramatic, but a new study indicates that existing statistics may not be accurate.
The study, published online April 6 in the British Journal of Nutrition, has found evidence of racial bias in the use of body mass index as a measurement of obesity, overstating the prevalence of obesity among blacks while understating it among Hispanic and Asian women.
The BMI uses “cut-scores” based on studies conducted long ago that used white adults, and the researchers in the study found that scores greater than 30 might more accurately reflect obesity for blacks, while lower scores might be a more suitable indicator for Hispanic, Asian and South Asian women. Under current measurements, a BMI of 30 indicates obesity for anyone of any race or sex.
Congress targets crime against retailers with ‘Protect Your Pharmacy Week’
NEW YORK The fact that Congress stepped up to designate the week of April 13 as “Protect Your Pharmacy Week” is important as it further acknowledges and supports the fight against the growing problem of crime against retailers.
As stated in the article, the concept of “Protect Your Pharmacy Week” was created last year to encourage pharmacists to protect themselves, staff and patients against pharmacy crime, including prescription drug theft. New for this year is the Protect Your Pharmacy Now! Prescription Disposal Program, which offers information and resources for pharmacies to create consumer drug disposal programs to help their patients safely dispose of unused and expired medicines that may be dangerous to others and to the environment.
The news came on the heels of a letter sent by Steve Anderson, NACDS president and CEO, to Reps. Brad Ellsworth, D-Ind., and Jim Jordan, R-Ohio, praising the introduction of the Organized Retail Crime Act of 2009. This bill would define organized crime, expand fraud to include the illegal use of gift cards, UPC labels or RFID and requests that the United States Sentencing Commission review and amend the sentencing guidelines for convicted offenders.
The NACDS has stated that organized retail crime is responsible for more than $30 billion in losses annually, resulting in increased costs for merchants, higher prices for consumers, and lost tax revenue for state and local governments. In addition to increased costs faced by retailers to cover losses and investment of additional security measures, consumers are placed at risk when tampering occurs on such health care products as infant formula and OTC medications.